Need help finding what you are looking for?
Contact Us
PUBLISHER: GlobalData | PRODUCT CODE: 1635624
PUBLISHER: GlobalData | PRODUCT CODE: 1635624
Glaucoma: 68-Market Analysis and Sales Forecast
PUBLISHED:
PAGES: 16 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
This report covers the 68 geographical markets and provides an Excel-based forecast model for the Glaucoma market through 2023.
Across the 68 markets, sales in the glaucoma market were $3.1 billion in 2023, growing to $6.8 billion in 2033.
The seven major markets (US, France, Germany, Italy, Spain, UK, and Japan) represent approximately 66.4% and 37.3% of 68-market sales in 2023 and 2033, respectively.
Scope
- This publication is an expanded version of the Excel model containing the patient-based forecast sales for glaucoma, covered in GlobalData's report "Glaucoma: Seven -Market Drug Forecast and Market Analysis Update", published in December 2024.
- In addition to patient based forecast sales data for the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan), this report contains sales forecast extrapolations for an additional 60 geographical markets (60M), totaling 68 markets (68M).
Reasons to Buy
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the 7MM glaucoma therapeutics market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the 7MM glaucoma therapeutics market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
Product Code: GDHC299PIDR-68M
Table of Contents
Table of Contents
- About GlobalData
1 Executive Summary
- 1.1 Overview
- 1.2 68M summary statistics
- 1.3 Key 7MM events driving the 68M forecast extrapolation.
2 Appendix
- 2.1 Abbreviations
- 2.2 Methodology
- 2.2.1 Patient-based forecast methodology
- 2.2.2 68M forecast extrapolation methodology.
- 2.3 Primary research - key opinion leaders interviewed for this report.
3 Primary research - prescriber survey
- 3.1 About the authors
- 3.1.1 Analyst
- 3.1.2 Therapy area and director
- 3.1.3 Epidemiologist
- 3.1.4 Vice president of disease intelligence and epidemiology
- 3.1.5 Global head of pharma research, analysis, and competitive intelligence
- Contact Us
Product Code: GDHC299PIDR-68M
List of Tables
- Table 1: Glaucoma market size across the 68M - 7MM versus 61M
- Table 2: Glaucoma market size across the 68M - by geographical region
- Table 3: Glaucoma, key events occurring in the 7MM driving forecast trajectory in the 68M
- Table 4: High-prescribing physicians (non-KOLs) surveyed, by country
List of Figures
- Figure 1: Glaucoma market size across the 68M - 7MM versus 61M
- Figure 2: Glaucoma market size across the 68M - by geographical region
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.